Tactile Systems Technology, Inc. (NASDAQ:TCMD) is set to issue its quarterly earnings data after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of $0.05 per share for the quarter.

Tactile Systems Technology (NASDAQ:TCMD) last issued its quarterly earnings data on Monday, August 7th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. The business had revenue of $26.30 million for the quarter, compared to analyst estimates of $23.88 million. Tactile Systems Technology had a return on equity of 3.05% and a net margin of 4.97%. Tactile Systems Technology’s quarterly revenue was up 33.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.04 EPS. On average, analysts expect Tactile Systems Technology to post $0.27 EPS for the current fiscal year and $0.21 EPS for the next fiscal year.

Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) opened at 28.69 on Wednesday. Tactile Systems Technology, Inc. has a 12 month low of $14.37 and a 12 month high of $37.88. The company’s 50-day moving average price is $31.84 and its 200-day moving average price is $28.30. The company has a market cap of $504.54 million, a price-to-earnings ratio of 108.67 and a beta of -0.01.

WARNING: “Tactile Systems Technology, Inc. (TCMD) Set to Announce Quarterly Earnings on Wednesday” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/11/01/tactile-systems-technology-inc-tcmd-set-to-announce-quarterly-earnings-on-wednesday.html.

In other news, VP Bryan Rishe sold 1,500 shares of Tactile Systems Technology stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $28.29, for a total value of $42,435.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Gerald R. Mattys sold 30,000 shares of Tactile Systems Technology stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $31.47, for a total value of $944,100.00. Following the completion of the transaction, the chief executive officer now owns 327,885 shares in the company, valued at approximately $10,318,540.95. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,074,910 shares of company stock worth $33,409,113. Company insiders own 49.90% of the company’s stock.

TCMD has been the topic of a number of research reports. Guggenheim initiated coverage on Tactile Systems Technology in a research report on Thursday, October 12th. They set a “buy” rating and a $47.00 price target on the stock. Zacks Investment Research upgraded Tactile Systems Technology from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research report on Thursday, August 10th. Canaccord Genuity reiterated a “buy” rating and issued a $37.00 price objective (up previously from $28.00) on shares of Tactile Systems Technology in a report on Tuesday, August 8th. ValuEngine upgraded Tactile Systems Technology from a “sell” rating to a “hold” rating in a report on Friday, July 28th. Finally, Northland Securities reiterated a “hold” rating and issued a $31.50 price objective on shares of Tactile Systems Technology in a report on Monday, October 16th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $35.75.

About Tactile Systems Technology

Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.

Receive News & Ratings for Tactile Systems Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.